NATCOPHARM
HealthcareNatco Pharma Limited
₹822.90
-6.00(-0.72%)
EMA 9: 808.33EMA 21: 802.92RSI: 65.8MACD: 2.03ATR: 24.04
Overlays
RSI (14)
Open
₹822.90
High
₹822.90
Low
₹822.90
Close
₹822.90
Volume
0
Natco Pharma Limited (NATCOPHARM) last closed at ₹822.9 on 17 Nov 2026, 32.4% below its 52-week high. Price is above the 50-day average but still below the 200-day. The scanner currently flags 20-Day High Breakout, MACD Bullish Crossover, Volume Breakout.
1 week
+2.3%
1 month
+4.8%
3 months
-6.8%
52-week high
₹1,216.8
-32.4% from high
52-week low
₹773.6
Volume vs 20-day
—
Active signals
20-Day High BreakoutBULLISH
New today-0.7%
MACD Bullish CrossoverBULLISH
New today-0.7%
Volume BreakoutBULLISH
Day 2 · since 13 Nov+1.5%
Signal history
| Dates | Signal | Type | Lasted | Quality | Move |
|---|---|---|---|---|---|
| 12 Nov | 20-Day High Breakout | BULLISH | 1d | Q60 | — |
| 11 Nov | EMA Crossover (9/21) | BULLISH | 1d | Q61 | — |
| 28 Oct – 03 Nov | Downtrend Alignment | BEARISH | 5d | Q39 | -1.4% |
| 21 Oct – 22 Oct | Downtrend Alignment | BEARISH | 2d | Q33 | +0.1% |
| 07 Oct – 16 Oct | Downtrend Alignment | BEARISH | 7d | Q34 | -3.1% |
| 30 Sept – 05 Oct | Downtrend Alignment | BEARISH | 3d | Q36 | +0.1% |
| 28 Sept | Downtrend Alignment | BEARISH | 1d | Q38 | — |
| 04 Aug – 22 Sept | Downtrend Alignment | BEARISH | 33d | Q31 | -11.1% |
| 30 Jul – 31 Jul | Downtrend Alignment | BEARISH | 2d | Q29 | -1.4% |
| 24 Jul – 28 Jul | Downtrend Alignment | BEARISH | 3d | Q29 | +0.4% |
| 24 Jul | EMA Death Cross (9/21) | BEARISH | 1d | Q29 | — |
| 23 Jul | MACD Bearish Crossover | BEARISH | 1d | Q38 | — |
| 10 Jul | MACD Bullish Crossover | BULLISH | 1d | Q63 | — |
| 07 Jul – 08 Jul | 20-Day High Breakout | BULLISH | 2d | Q76 | -1.8% |
| 07 Jul | EMA Crossover (9/21) | BULLISH | 1d | Q76 | — |
| 07 Jul | RSI Momentum Expansion | BULLISH | 1d | Q76 | — |
| 07 Jul | Volume Breakout | BULLISH | 1d | Q76 | — |
Explosion screen appearances
07 Jul 2026
Day +5.9% on 3.3× volume
Next day -1.8%
Healthcare peers
Technical data for educational purposes only — not investment advice